Potential applications of apoptosis in modifying the biological behavior of therapeutically refractory cancers
- 31 October 1994
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 43 (4), 207-213
- https://doi.org/10.1016/0306-9877(94)90067-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Premature p34 cdc2 Activation Required for ApoptosisScience, 1994
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Apoptotic cell death induced by c-myc is inhibited by bcl-2Nature, 1992
- p53, guardian of the genomeNature, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosisClinical and Experimental Immunology, 1990
- The Importance of Immunesenescence in the Incidence and Malignant Properties of Cancer in Hosts of Advanced AgeJournal of Gerontology, 1989
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972